These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12114747)

  • 1. Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
    Koch CA; Mauro D; Walther MM; Linehan WM; Vortmeyer AO; Jaffe R; Pacak K; Chrousos GP; Zhuang Z; Lubensky IA
    Endocr Pathol; 2002; 13(1):17-27. PubMed ID: 12114747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
    Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
    Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.
    Brouwers FM; Gläsker S; Nave AF; Vortmeyer AO; Lubensky I; Huang S; Abu-Asab MS; Eisenhofer G; Weil RJ; Park DM; Linehan WM; Pacak K; Zhuang Z
    Endocr Relat Cancer; 2007 Jun; 14(2):463-71. PubMed ID: 17639059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
    Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
    Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral pheochromocytomas.
    Kalff V; Shapiro B; Lloyd R; Nakajo M; Sisson JC; Beierwaltes WH
    J Endocrinol Invest; 1984 Aug; 7(4):387-92. PubMed ID: 6150055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.
    Arao T; Okada Y; Tanikawa T; Inatomi H; Shuin T; Fujihira T; Yamashita H; Tanaka Y
    Endocr J; 2002 Apr; 49(2):181-8. PubMed ID: 12081237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bilateral pheochromocytomas with von Hippel-Lindau disease: a case report].
    Masunaga K; Inadome A; Sugiyama Y; Maeda Y; Satoji Y; Takahashi W; Yoshida M; Ueda S; Ikeda K; Takano Y; Yatsuda J
    Nihon Hinyokika Gakkai Zasshi; 2007 Nov; 98(7):843-7. PubMed ID: 18062217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
    Gosset P; Lecomte-Houcke M; Duhamel A; Labat-Moleur F; Patey M; Floquet J; Viennet G; Berger-Dutrieux N; Caillou B; Franc B
    Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.
    Abbott MA; Nathanson KL; Nightingale S; Maher ER; Greenstein RM
    Am J Med Genet A; 2006 Apr; 140(7):685-90. PubMed ID: 16502427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
    Perren A; Komminoth P
    Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
    Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current opinion in pathogenesis of pheochromocytoma].
    Mazurkiewicz M; Wasiutyński A
    Pol Merkur Lekarski; 2007 Jun; 22(132):509-13. PubMed ID: 17874618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.